İş Yatırım's address looks calm in the report: Levent Mahallesi, İş Kuleleri Kule-2, Floor 13. But this quarter, no calm number passed across that floor's accounting screen. The income statement wrote 470.4 billion TL in sales. This is not the product shipped by a factory; it is the large shadow of capital-market traffic falling into the ledger. The real economic pool narrowed to 8.27 billion TL at the gross profit line. The net profit left to the parent company's shareholders was 846 million TL.
That is why calling ISMEN a "brokerage house" is incomplete. The company is İş Bankası's publicly traded capital-markets counter: equities, VİOP, warrants, share lending, debt issuance, corporate finance, research, İş Portföy, and digital channels are different mouths of the same machine. Türkiye İş Bankası controls it with a 65.74% stake; the free float is 29.2%. Class A shares carry the privilege to nominate six members of the board. In other words, this is not a scattered market game; it is an institutional fee and risk machine operating under the İş Bankası roof.
The machine is working. In the first quarter of 2026, İş Yatırım ranked third in Borsa İstanbul Equity Market with 3.075 billion TL in trading volume and a 9.3% market share. In VİOP, it ranked second with 2.541 billion TL in trading volume and a 12.2% market share. Share loan size rose 21% year over year to 17.384 billion TL. Consolidated assets managed by subsidiary İş Portföy increased 83% year over year to 1.462 trillion TL; mutual fund size reached 959 billion TL, while pension funds reached 418 billion TL.
Yet even in good capital-markets companies, scale alone is not a thesis. The real issue in İş Yatırım's Q1 statement is how cleanly that size flows to its owner. In the first quarter of 2026, gross profit was 8.27 billion TL; within that, net interest and derivatives income was 4.11 billion TL, net service income was 2.76 billion TL, gross profit from trading activity was 874 million TL, and other operating income was 518 million TL. This is a good counter pool. But once operating expenses rose to 3.46 billion TL, operating profit was left at 4.90 billion TL. Then came a 2.10 billion TL net monetary position loss and 1.35 billion TL in tax expense. The shareholder's pocket thinned there.
| Line item | 2026Q1 | 2025Q1 | Read-through |
|---|---|---|---|
| Gross profit | TRY 8.270bn | TRY 8.453bn | The economic revenue pool was broadly flat. |
| Operating profit | TRY 4.902bn | TRY 5.994bn | Expenses pulled margins down. |
| Net monetary-position loss | TRY -2.101bn | TRY -3.243bn | TMS 29 remains a large filter. |
| Parent net income | TRY 846m | TRY 1.491bn | Shareholder profit fell 43% year on year. |
The picture hardens when compared with the same quarter of 2025. Parent-company net profit fell from 1.49 billion TL to 846 million TL; operating profit declined from 5.99 billion TL to 4.90 billion TL. Moreover, in the first quarter of 2025 there was 2.33 billion TL of income from investing activities; in the first quarter of 2026 that line was absent. So the sentence "profit fell" is lazy on its own. The correct sentence is this: ISMEN's operating machine is still large, but in the first quarter of 2026 the non-operating and inflation-accounting filter shrank shareholder profit.
That is why there is no easy sleep on the balance sheet side. Total assets rose in three months from 129.54 billion TL to 165.68 billion TL. Short-term liabilities jumped from 84.93 billion TL to 125.72 billion TL. The ratio of current assets to short-term liabilities fell from 1.39 to 1.23. The ratio of total liabilities to total equity rose from 2.14 to 3.51. Equity attributable to the parent declined from 35.63 billion TL to 31.42 billion TL. Cash flow includes a 5.05 billion TL dividend payment; that is roughly six times Q1 parent-company profit.
This does not make the company "distressed." İş Yatırım has 41.09 billion TL in cash and cash equivalents; 24.55 billion TL in financial investments; and 17.06 billion TL of positive operating cash flow in Q1. But reading cash flow in a capital-markets company as if it were an industrial company is misleading. The real test here is whether customer receivables, share loans, counterparty risk, leverage, and short-term liabilities deteriorate at the same time. Management also says in the risk section that it monitors market, asset-liability, credit, counterparty, operational, information technology, reputation, and compliance risks separately, and uses VaR, backtesting, and stress testing. That is good control language. But for the investor, control language is examined in the next bad market.
| Metric | 31 March 2026 | 31 December 2025 / comparison | Why it matters |
|---|---|---|---|
| Current assets / short-term liabilities | 1,23x | 1,39x | The liquidity buffer narrowed. |
| Total liabilities / total equity | 3,51x | 2,14x | Leverage increased. |
| Parent equity | TRY 31.421bn | TRY 35.634bn | Dividend and period movements reduced book value. |
| Margin loan balance | TRY 17.384bn | YoY +21% | Credit and counterparty exposure is growing. |
Valuation is where this gets interesting. At the 18 May 2026 price, market value is 59.52 billion TL. Since 2026Q1 parent-company equity is 31.42 billion TL, the market is paying 1.89 times book value. That is not a cheap book multiple. But when the last four quarters of parent-company profit are roughly calculated, another face appears: 2025 year-end parent-company profit was 8.19 billion TL; after removing 2025Q1 and adding 2026Q1, TTM parent-company profit is approximately 7.55 billion TL. The market is paying 7.9 times that. That is not expensive either.
| Approach | Input | Result | Read-through |
|---|---|---|---|
| Market value / book value | TRY 59.52bn / TRY 31.42bn | 1.89x | Not cheap on book value. |
| TTM parent earnings | 2025 FY 8.193 - 2025Q1 1.491 + 2026Q1 0.846 | TRY 7.548bn | Four-quarter earnings capacity remains visible. |
| Market value / TTM earnings | TRY 59.52bn / TRY 7.548bn | 7.9x | Reasonably cheap on earnings. |
| Normalized earnings range | TRY 7.5-8.5bn x 8-10x | TRY 60-85bn | Current value sits near the low end. |
One more control is necessary here: ISMEN is not only parent-company profit. Inside the consolidated structure there is a scaled asset-management arm such as İş Portföy, subsidiaries, and non-controlling interests. That is why leaving the earnings multiple naked would make the report incomplete. Market value is 59.52 billion TL; non-controlling interests on the consolidated balance sheet are 5.31 billion TL. Adding that stake at book value and roughly weighing the platform at 64.83 billion TL, with TTM parent-company profit of 7.55 billion TL and an annualized approximate 0.10 billion TL contribution from Q1 minority profit, the look-through earnings multiple comes to around 8.5x. Even if a harsher value such as 1.5-2.0 times book is assigned to the minority interest, this multiple only rises roughly to the 8.8-9.2x range.
In the second approach, weighing the company by normalized earnings rather than book is fairer. But then the inside of the range must be filled. In the first quarter of 2026, the gross profit pool was 8.27 billion TL; financial-sector gross profit was 7.40 billion TL; net interest and derivatives income was 4.11 billion TL; net service income was 2.76 billion TL. Last-four-quarter parent-company profit was 7.55 billion TL. So a 7.5-8.5 billion TL normalized parent-company profit assumption is not a growth dream falling from the sky; it is a platform reading that preserves the last-four-quarter line despite Q1 weakness. An 8-10x earnings band does not give this structure the multiple of a flawless asset manager; it uses a financial-platform multiple that already carries a discount for leverage, TAS 29, share loans, and the market cycle. The feet of this band are 60-85 billion TL of equity value. The current 59.52 billion TL market value sits at the lower end of the band.
| Case | Annual parent earnings | Multiple | Equity value |
|---|---|---|---|
| Bear | TRY 6.0bn | 7x | TRY 42bn |
| Base | TRY 7.5bn | 8x | TRY 60bn |
| Bull | TRY 8.5bn | 10x | TRY 85bn |
This does not paste a blind "cheap" label onto the stock; but it shows that the market is no longer buying much of a growth dream. In the bear case, annual parent-company profit falls to 6.0 billion TL and if the market gives nothing more than a 7x multiple, value can loosen to 42 billion TL. The base case, with 7.5 billion TL of profit and an 8x multiple, sits almost exactly on today's market value. The bull case, with 8.5 billion TL of profit and a 10x multiple, rises to 85 billion TL. This table does not make ISMEN riskless; it makes it asymmetric: the market is already standing at the lower door of the base case; the thesis rests on the platform not falling permanently into the bear case.
The fair anti-thesis is strong. Q1 parent-company profit fell 43% year over year. Equity Market share was 10.9% in 2025/3 and declined to 9.3% in 2026/3. Short-term liabilities grew sharply. Share loans rose to 17.384 billion TL. The TAS 29 loss and the tax line can weaken the shareholder even when operating profit is good. And while the dividend tradition looks pleasant, in a weak quarter it is a real capital outflow that pulls equity down.
But the other side must also be seen. This company does not have a single commission button in its hand. It has a strong position in VİOP, warrant market making, 53.4 billion TL of intermediation in debt instrument issuances, 1.462 trillion TL of assets under management at İş Portföy, 36 branches, and distribution power coming through the İş Bankası branch network. On the research side, 69 companies representing 55% of Borsa İstanbul Equity Market free-float value are regularly covered. This scale provides enough evidence not to turn a bad quarter immediately into permanent collapse.
Therefore my decision: Cheap. Cheap does not mean "riskless"; on book value, it is already not cheap. The cheapness comes from the current price acting too harshly, as if ISMEN's 2025-2026 earnings capacity has been permanently broken. The stock is for the investor who can tolerate the quarter-to-quarter profit swings of a highly leveraged capital-markets machine. It is not for the investor seeking regular, clean, industrial-type cash flow.
The data that would break the thesis are very clear: if in the next quarter parent-company profit again remains below 1 billion TL, if the total liabilities/equity ratio stands around or above 3.5x, if the current assets/short-term liabilities ratio falls below 1.20, or if share loans grow from the 17.4 billion TL level without a corresponding increase in gross profit, this "cheap counter" narrative weakens. The dividend outflow must also be watched: the 5.05 billion TL dividend paid in Q1 was roughly six times the parent-company profit of the same quarter. For now, owning ISMEN is not a belief that the counter in Levent counts a great deal of money; it is a belief that from that money, it can again leave a thicker share for the shareholder.